-
PDF
- Split View
-
Views
-
Cite
Cite
Nicholas R. Stephens, Zhi Qi, Edgar P. Spalding, Glutamate Receptor Subtypes Evidenced by Differences in Desensitization and Dependence on the GLR3.3 and GLR3.4 Genes, Plant Physiology, Volume 146, Issue 2, February 2008, Pages 323–324, https://doi.org/10.1104/pp.107.108134
Close - Share Icon Share
Abstract
Ionotropic glutamate (Glu) receptors in the central nervous system of animals are tetrameric ion channels that conduct cations across neuronal membranes upon binding Glu or another agonist. Plants possess homologous molecules encoded by GLR genes. Previous studies of Arabidopsis thaliana root cells showed that the amino acids alanine (Ala), asparagine (Asn), cysteine (Cys), Glu, glycine (Gly), and serine trigger transient Ca2+ influx and membrane depolarization by a mechanism that depends on the GLR3.3 gene. This study of hypocotyl cells demonstrates that these six effective amino acids are not equivalent agonists. Instead, they grouped into hierarchical classes based on their ability to desensitize the response mechanism. Sequential treatment with two different amino acids separated by a washout phase demonstrated that Glu desensitized the depolarization mechanism to Gly, but Gly did not desensitize the mechanism to Glu. All 36 possible pairs of agonists were tested to characterize the desensitization hierarchy. The results could be explained by a model in which one class of channels contained a subunit that was activated and therefore desensitized only by Glu, while a second class could be activated and desensitized by Ala, Cys, Glu, or Gly. A third class could be activated and desensitized by any of the six effective amino acids. Analysis of knockout mutants indicated that GLR3.3 was a required component of all three classes of channels, while the related GLR3.4 molecule specifically affected only two of the classes. The resulting model is an important step toward understanding the biological roles of these enigmatic ion channels.
One surprise to emerge from the first comprehensive inventory of a plant genome (Arabidopsis Genome Initiative, 2000) was the identification of a family of 20 genes unequivocally homologous to mammalian ionotropic Glu receptors (Lam et al., 1998; Lacombe et al., 2001). Such receptors function as ligand-gated ion channels in the mechanism that transmits signals between cells in the central nervous system (Madden, 2002; Mayer, 2005). At the junction between two neurons, or synapse, the presynaptic cell releases the neurotransmitter Glu, which binds to ionotropic Glu receptors located at the plasma membrane of the postsynaptic cell. Ionotropic Glu receptors are tetrameric ion channels. They respond to the binding of Glu by adopting a conformation that permits mixed cation flow into the postsynaptic cell, resulting in membrane depolarization (Madden, 2002). The channels quickly shift to a nonconducting (desensitized) conformation, which can be exited after unbinding of the agonist (Sun et al., 2002). Removal of Glu from the extracellular space promotes agonist unbinding and therefore recovery of sensitivity.
Depending on the types of subunits constituting a particular Glu receptor channel, Ca2+ may accompany Na+ and K+ ions flowing into the postsynaptic cell (Dingledine et al., 1999). In these cases, a rise in intracellular Ca2+ accompanies the membrane depolarization. The rise in Ca2+ plays a role in regulating synaptic transmission efficiency, which underpins learning and other central nervous system processes (Ghosh and Greenberg, 1995). Misregulation of synaptic activities mediated by Glu receptors is associated with neurodegenerative diseases including Alzheimer's, Parkinson's, and Huntington's diseases (Olney et al., 1998; Schiffer, 2002; Barnes and Slevin, 2003).
Because the ionotropic Glu receptors are studied mostly in the context of central nervous system signaling, it was a surprise to find genes having all the hallmarks of common ancestry, and even common function, in the genomes of plants (Davenport, 2002). Using hindsight, evidence of their existence can be seen in early plant electrophysiological studies. Etherton and colleagues demonstrated that large, transient membrane depolarizations were triggered by some amino acids and that the response displayed desensitization (Etherton and Rubinstein, 1978; Novacky et al., 1978). Models based on electrogenic amino acid transport were constructed to explain the results (Kinraide and Etherton, 1980, 1982), but the possibility that plants possess amino acid-gated ion channels was not yet raised. After the GLR genes were discovered, the phenomenon of amino acid-triggered ionic events in plants cells was investigated with a different model in mind. A study of Arabidopsis (Arabidopsis thaliana) roots showed that membrane depolarization in response to Glu was accompanied by a large spike in intracellular Ca2+ (Dennison and Spalding, 2000). A subsequent reverse-genetic study linked GLR3.3, one of the 20 Arabidopsis GLR genes, to the membrane depolarization and the Glu-induced Ca2+ rise (Qi et al., 2006). Mutation of GLR3.3 severely impaired both the membrane depolarization and the Ca2+ rise triggered by Glu in the micromolar to millimolar concentration range (Qi et al., 2006). These results leave little room for doubt that the plant GLR molecules are components of ligand-gated ion channels that transiently conduct cations, including Ca2+, into plant cells.
Other work on the GLR gene family has indicated a variety of roles for members of the gene family in plant physiology. These roles include regulation of hypocotyl elongation (Lam et al., 1998; Dubos et al., 2003), sensing of mineral nutrient status (Kim et al., 2001), regulating carbon/nitrogen balance (Kang and Turano, 2003), resisting aluminum toxicity (Sivaguru et al., 2003) and cold (Meyerhoff et al., 2005), root meristem function (Li et al., 2006; Walch-Liu et al., 2006), as well as jasmonate-mediated defense mechanisms (Kang et al., 2006).
While some evidence indicates that plant Glu receptors function much like their animal homologs, other results point to important differences. Sequence similarity between the Arabidopsis GLRs and animal iGluRs is high in the transmembrane domains (Chiu et al., 1999, 2002), but the N termini of the Arabidopsis GLRs may have come from ancestral amino acid-binding G-protein-coupled receptors (Turano et al., 2001). Structure modeling indicates that the plant molecules may have an additional amino acid binding site not present in animal iGluRs (Acher and Bertrand, 2005). Perhaps related to these potentially atypical binding sites, Qi et al. (2006) found that six very different amino acids were capable of triggering membrane depolarization and a Ca2+ rise. The effective amino acids were Ala, Asn, Cys, Glu, Gly, and Ser. Even glutathione (a tripeptide consisting of Glu-Gly-Cys) triggered a full response. Responses to all six effective amino acids and glutathione were equally impaired by glr3.3 mutations (Qi et al., 2006). These results provided genetic evidence that a GLR molecule was mechanistically related to the ionic events triggered by an amino acid. More specifically, these results indicated that that GLR3.3 is a necessary subunit of channels that respond to all six amino acids and the tripeptide. A question raised by the surprisingly broad agonist profile is whether or not all six effective amino acids are equivalent and whether or not other GLR family members contribute to the breadth of the profile. For example, do heteromeric channels differing in subunit composition have different agonist profiles? This study takes advantage of the desensitization phenomenon and mutations in the GLR3.3 and GLR3.4 genes to address these questions.
RESULTS
A, Wild-type hypocotyl response to Gly. Typical membrane depolarization induced by switching from buffer to 1 mm Gly. B, Distribution of resting potentials and peak potentials from Gly-treated hypocotyl cells. Resting potential values (black) are normally distributed with a mean and median of −141 mV. The peak membrane potentials reached following application of 1 mm Gly (red) are right-hand skewed (mean = −49 mV, median = −42 mV). C, Hypocotyl segments show similar Ca2+ transients as those of whole seedlings. Transgenic aequorin-expressing hypocotyl segments were used to monitor responses to addition of Glu (blue) or Gly (orange). Final concentration of each agonist was 1 mm. Each curve represents the mean of three trials of 10 hypocotyl segments each (with se) with the exception of the buffer control, which was performed only once. Raw luminescence data was divided by the average pretreatment luminescence value to normalize each trace, taking into account tissue variability and differences in coelenterazine uptake.
Wild-type and glr3.3 depolarizations in response to the six potent amino acids. Two independent alleles of glr3.3 (glr3.3-1, red; glr3.3-2, blue) displayed significantly smaller depolarizations than wild type in response to all six potent amino acids tested. Shown here are typical recordings collected on the same days. Mean peak values are shown in Figure 6B.
Depolarization-Independent Desensitization
Desensitization of cells by prior agonist application. Exposure to 1 mm Glu (A) followed by a 2-min wash with buffer resulted in a substantially smaller depolarization by a second Glu treatment. B, Gly also renders the cell insensitive to a second Gly treatment. C, Gly elicited a substantially reduced depolarization when the pH of the extracellular medium was increased from 5.7 to 7.7, but the cell was still desensitized to a subsequent treatment with Gly at the permissive pH of 5.7.
Asymmetric Desensitization
Serial amino acid treatments revealed asymmetric relationships between different agonists. A, Ala was ineffective following Glu application, but Glu was fully effective following Ala (B). Shown here are typical recordings of the Glu→Ala and Ala→Glu treatments. Mean peak values of second depolarizations are listed in Table I.
Desensitization of wild-type hypocotyl cells by paired treatments
Shown in the table are peak membrane potential values reached in response to a second amino acid treatment (mV ± se). Initial treatments are indicated under “First Treatment” and second treatments are indicated under “Second Treatment.” Bold type indicates diminished responses to the second treatment, or desensitization.
Second Treatment . | First Treatment . | . | . | . | . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | None . | Ala . | Asn . | Cys . | Glu . | Gly . | Ser . | ||||||
| Ala | −48 ± 3 | −117 ± 16 | −43 ± 6 | −69 ± 9 | −117 ± 15 | −98 ± 3 | −93 ± 8 | ||||||
| n = 45 | n = 3 | n = 3 | n = 5 | n = 3 | n = 3 | n = 12 | |||||||
| Asn | −76 ± 4 | −108 ± 2 | −110 ± 4 | −99 ± 11 | −89 ± 16 | −101 ± 11 | −76 ± 11 | ||||||
| n = 36 | n = 2 | n = 3 | n = 2 | n = 3 | n = 3 | n = 5 | |||||||
| Cys | −46 ± 4 | −78 ± 22 | −62 ± 19 | −96 ± 11 | −113 ± 4 | −95 ± 9 | −47 ± 5 | ||||||
| n = 35 | n = 3 | n = 4 | n = 3 | n = 3 | n = 3 | n = 3 | |||||||
| Glu | −37 ± 3 | −47 ± 6 | −34 ± 3 | −52 ± 3 | −135 ± 5 | −42 ± 8 | −36 ± 4 | ||||||
| n = 50 | n = 3 | n = 3 | n = 3 | n = 3 | n = 11 | n = 3 | |||||||
| Gly | −49 ± 3 | −87 ± 6 | −52 ± 12 | −102 ± 12 | −123 ± 5 | −108 ± 11 | −48 ± 2 | ||||||
| n = 88 | n = 4 | n = 3 | n = 3 | n = 4 | n = 6 | n = 3 | |||||||
| Ser | −57 ± 3 | −125 ± 6 | −85 ± 6 | −101 ± 7 | −106 ± 15 | −79 ± 14 | −97 ± 3 | ||||||
| n = 49 | n = 3 | n = 3 | n = 3 | n = 3 | n = 3 | n = 3 | |||||||
Second Treatment . | First Treatment . | . | . | . | . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | None . | Ala . | Asn . | Cys . | Glu . | Gly . | Ser . | ||||||
| Ala | −48 ± 3 | −117 ± 16 | −43 ± 6 | −69 ± 9 | −117 ± 15 | −98 ± 3 | −93 ± 8 | ||||||
| n = 45 | n = 3 | n = 3 | n = 5 | n = 3 | n = 3 | n = 12 | |||||||
| Asn | −76 ± 4 | −108 ± 2 | −110 ± 4 | −99 ± 11 | −89 ± 16 | −101 ± 11 | −76 ± 11 | ||||||
| n = 36 | n = 2 | n = 3 | n = 2 | n = 3 | n = 3 | n = 5 | |||||||
| Cys | −46 ± 4 | −78 ± 22 | −62 ± 19 | −96 ± 11 | −113 ± 4 | −95 ± 9 | −47 ± 5 | ||||||
| n = 35 | n = 3 | n = 4 | n = 3 | n = 3 | n = 3 | n = 3 | |||||||
| Glu | −37 ± 3 | −47 ± 6 | −34 ± 3 | −52 ± 3 | −135 ± 5 | −42 ± 8 | −36 ± 4 | ||||||
| n = 50 | n = 3 | n = 3 | n = 3 | n = 3 | n = 11 | n = 3 | |||||||
| Gly | −49 ± 3 | −87 ± 6 | −52 ± 12 | −102 ± 12 | −123 ± 5 | −108 ± 11 | −48 ± 2 | ||||||
| n = 88 | n = 4 | n = 3 | n = 3 | n = 4 | n = 6 | n = 3 | |||||||
| Ser | −57 ± 3 | −125 ± 6 | −85 ± 6 | −101 ± 7 | −106 ± 15 | −79 ± 14 | −97 ± 3 | ||||||
| n = 49 | n = 3 | n = 3 | n = 3 | n = 3 | n = 3 | n = 3 | |||||||
Desensitization of wild-type hypocotyl cells by paired treatments
Shown in the table are peak membrane potential values reached in response to a second amino acid treatment (mV ± se). Initial treatments are indicated under “First Treatment” and second treatments are indicated under “Second Treatment.” Bold type indicates diminished responses to the second treatment, or desensitization.
Second Treatment . | First Treatment . | . | . | . | . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | None . | Ala . | Asn . | Cys . | Glu . | Gly . | Ser . | ||||||
| Ala | −48 ± 3 | −117 ± 16 | −43 ± 6 | −69 ± 9 | −117 ± 15 | −98 ± 3 | −93 ± 8 | ||||||
| n = 45 | n = 3 | n = 3 | n = 5 | n = 3 | n = 3 | n = 12 | |||||||
| Asn | −76 ± 4 | −108 ± 2 | −110 ± 4 | −99 ± 11 | −89 ± 16 | −101 ± 11 | −76 ± 11 | ||||||
| n = 36 | n = 2 | n = 3 | n = 2 | n = 3 | n = 3 | n = 5 | |||||||
| Cys | −46 ± 4 | −78 ± 22 | −62 ± 19 | −96 ± 11 | −113 ± 4 | −95 ± 9 | −47 ± 5 | ||||||
| n = 35 | n = 3 | n = 4 | n = 3 | n = 3 | n = 3 | n = 3 | |||||||
| Glu | −37 ± 3 | −47 ± 6 | −34 ± 3 | −52 ± 3 | −135 ± 5 | −42 ± 8 | −36 ± 4 | ||||||
| n = 50 | n = 3 | n = 3 | n = 3 | n = 3 | n = 11 | n = 3 | |||||||
| Gly | −49 ± 3 | −87 ± 6 | −52 ± 12 | −102 ± 12 | −123 ± 5 | −108 ± 11 | −48 ± 2 | ||||||
| n = 88 | n = 4 | n = 3 | n = 3 | n = 4 | n = 6 | n = 3 | |||||||
| Ser | −57 ± 3 | −125 ± 6 | −85 ± 6 | −101 ± 7 | −106 ± 15 | −79 ± 14 | −97 ± 3 | ||||||
| n = 49 | n = 3 | n = 3 | n = 3 | n = 3 | n = 3 | n = 3 | |||||||
Second Treatment . | First Treatment . | . | . | . | . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | None . | Ala . | Asn . | Cys . | Glu . | Gly . | Ser . | ||||||
| Ala | −48 ± 3 | −117 ± 16 | −43 ± 6 | −69 ± 9 | −117 ± 15 | −98 ± 3 | −93 ± 8 | ||||||
| n = 45 | n = 3 | n = 3 | n = 5 | n = 3 | n = 3 | n = 12 | |||||||
| Asn | −76 ± 4 | −108 ± 2 | −110 ± 4 | −99 ± 11 | −89 ± 16 | −101 ± 11 | −76 ± 11 | ||||||
| n = 36 | n = 2 | n = 3 | n = 2 | n = 3 | n = 3 | n = 5 | |||||||
| Cys | −46 ± 4 | −78 ± 22 | −62 ± 19 | −96 ± 11 | −113 ± 4 | −95 ± 9 | −47 ± 5 | ||||||
| n = 35 | n = 3 | n = 4 | n = 3 | n = 3 | n = 3 | n = 3 | |||||||
| Glu | −37 ± 3 | −47 ± 6 | −34 ± 3 | −52 ± 3 | −135 ± 5 | −42 ± 8 | −36 ± 4 | ||||||
| n = 50 | n = 3 | n = 3 | n = 3 | n = 3 | n = 11 | n = 3 | |||||||
| Gly | −49 ± 3 | −87 ± 6 | −52 ± 12 | −102 ± 12 | −123 ± 5 | −108 ± 11 | −48 ± 2 | ||||||
| n = 88 | n = 4 | n = 3 | n = 3 | n = 4 | n = 6 | n = 3 | |||||||
| Ser | −57 ± 3 | −125 ± 6 | −85 ± 6 | −101 ± 7 | −106 ± 15 | −79 ± 14 | −97 ± 3 | ||||||
| n = 49 | n = 3 | n = 3 | n = 3 | n = 3 | n = 3 | n = 3 | |||||||
Concentration dependence of amino acid-induced Ca2+ increases. Transgenic aequorin-expressing seedlings were used to compare the Ca2+ transients caused by the six potent amino acids. A, Integration of 25-s recordings following injection of agonists at specified concentrations. Each recording was first normalized by the total luminescence following discharge with 2 m CaCl2, 10% ethanol, then integrated. Ser and Asn gave the weakest increases in cytosolic calcium, while Cys triggered the largest increases. Treatment with 1 μ m of any of the potent amino acids failed to elicit a detectable response above that of buffer injection. B, Data from A shown as a percentage of the maximal response by dividing each integration by the average response to 10,000 μ m agonist and offset by subtracting the responses to buffer control injection. Approximate half-maximal concentration of the different agonists occurs around 100 μ m, possibly lower for Cys.
Different Contributions of GLR3.3 and GLR3.4
A, Wild-type and glr3.4 depolarizations in response to the six potent amino acids. Two independent alleles of glr3.4 (glr3.4-1, blue; glr3.4-2, magenta) displayed significantly smaller depolarizations than wild type in response to some of the six potent amino acids tested. The greatest differences between wild type and mutants are seen in responses to Asn and Ser; smaller differences can be seen in Gly and Ala. Shown here are typical recordings collected on the same days. B, Peak membrane potential values for wild-type, glr3.3, and glr3.4 hypocotyls in response to the six potent amino acids (values in Supplemental Table S1). The mean resting potential ± se is indicated by a double line.
To determine whether or not the role of GLR3.4 was equivalent in other tissues, responses of glr3.4 root cells to Ser or Gly were also measured with intracellular microelectrodes. The Ser and Gly depolarizations in glr3.4 root cells were in all respects similar to those of the wild type (Supplemental Fig. S2). This is consistent with the expression of GLR3.4 being higher in the shoot than the root (Meyerhoff et al., 2005).
DISCUSSION
An important question raised by the previous work of Qi et al. (2006) was how six unrelated amino acids could each be an agonist of GLR3.3-dependent ion channels. Possible explanations included different GLR3.3-containing channel types, each specifically activated by a different amino acid, or, at the other extreme, one or more GLR3.3-containing channel types each activated by any of the six effective amino acids. The cross-desensitization data shown in Figure 4 and in Table I provide some critical information germane to the question. If each effective amino acid activated a specific channel type, then one ligand should not affect the sensitivity of the membrane to another. A Gly→Glu treatment should produce the same result as a Glu→Gly treatment. However, a Gly→Glu treatment elicited two full depolarizations, while a Glu→Gly treatment produced one full depolarization and a second response suppressed by desensitization. The first example is consistent with desensitization being due to a specific agonist-channel pair undergoing activity-based or homologous desensitization (Gainetdinov et al., 2004), but the second example is inconsistent with each agonist independently activating and desensitizing a specific channel.
The other scenario, in which all six effective amino acids are equivalent agonists of a channel, predicts that the first treatment should always desensitize the mechanism to the second treatment regardless of which amino acid was delivered first. The observed asymmetry in the cross-desensitization relationships appears to rule out this scenario. A caveat requiring investigation was the possibility that multiple agonists of a common channel differed by degree of potency in a manner that created a desensitization hierarchy. The dose response curves in Figure 5 weaken this possibility, as there was no clear correlation between potency and position in the hierarchy. Another related possibility is that during the 2-min washout period, agonists with a faster off-rate would unbind and leave the receptor sensitized, while agonists with a slower off-rate would remain bound to the receptor, leaving it desensitized. However, if a Ser→Glu treatment produced two full depolarizations because Ser unbinds during a 2-min wash, then Ser→Ser should also produce two full depolarizations. But, without exception, x→x treatments produced one full depolarization and a second desensitized response. Lastly, the observation that Glu was fully effective even in the continuous presence of Gly or Asn, i.e. Gly→Glu + Gly or Asn→Glu + Asn treatments (data not shown), argues against the six effective amino acids interchangeably activating the same channels. The above observations also argue against a form of desensitization in which activation induces a conformation that has a new high affinity for the agonist and is nonconducting. If “high affinity” desensitization (Giniatullin et al., 2005) was a major contributor to the hypocotyl cell behavior, then no second treatment should be effective. Collectively, the experimental observations do not support a model in which each of the six effective amino acids activates and desensitizes the same pool of receptor channels. The six effective amino acids do not function as equivalent agonists.
Proposed model of GLR channel subtypes in Arabidopsis hypocotyls based on wild-type and mutant data. Three types of multimeric ligand gated ion channels span the plasma membrane of light-grown hypocotyls: types A, B, and C. These channel subtypes are composed of functionally different subunits that confer amino acid-binding specificity. Loss of an essential subunit present in all three subtypes, GLR3.3, completely abolishes any channel function; likewise, activation by Glu results in activation and desensitization of all channels. Mutations in a nonessential subunit, GLR3.4, or treatment with a lesser agonist (Asn or Ser) results in a significant reduction of some channel activities (type C) with little effect on the remaining channels (types B and A).
A derivative of this model, equally consistent with the data, has each GLR subunit possessing two binding sites: an LAOBP domain (traditional Glu binding site) and an N-terminal LIVBP-binding domain for other amino acids (Felder et al., 1999; Bouché et al., 2003; Acher and Bertrand, 2005). In this case, all subunits would be able to bind Glu as well as another agonist, and type A channels would be an unnecessary feature of the model.
The desensitization phenomenon was exploited here to distinguish subtypes of receptor channels and to discern differences between the actions of the different effective amino acids. But the results also give some insight into the desensitization mechanism per se. Presentation of the agonist, not the subsequent ionic effects, is apparently the key event because desensitization occurred at a pH in which ion conduction was greatly suppressed. Thus, the desensitization phenomena reflect processes at or close to the receptor channel, such as ligand binding and conformational changes, rather than downstream consequences of the large ionic changes. Heterologous desensitization, in which activation of one receptor leads to desensitization of another type of receptor often by a signal transduction chain (Steele et al., 2002; Gainetdinov et al., 2004), therefore seems less probable. If heterologous desensitization contributes to the phenomena studied here, the mechanism coupling the different receptors appears not to depend on ion conduction. Instead, the simplest interpretation may be that binding of an effective amino acid by a GLR subunit causes the channel to pass from a closed state through a conducting state and into a desensitized state (Giniatullin et al., 2005). Recovery from the desensitized state may follow from agonist unbinding or from synthesis of new receptor channels as suggested by Meyerhoff et al. (2005).
The model presented here will guide the construction of higher order mutants that may produce informative phenotypes. The model may also guide heterologous expression studies and indicate which agonist(s) should be used to activate the expressed channels. For example, Meyerhoff et al. (2005) reported observing Glu-independent cation currents in GLR3.4-expressing Xenopus oocytes. Perhaps Glu was ineffective because it is not a good agonist of GLR3.4. Experiments using NMDA receptors serve as precedent for such a possibility. The NR3A or NR3B subunit, when coexpressed with the NR1 subunit, produced Gly-gated, Glu-insensitive cation channels (Chatterton et al., 2002). This example illustrates why elucidating the basic properties of agonist behavior and desensitization, and attributing them to particular genes, is an important objective in the overall effort to learn the biological function of this intriguing family of receptor channels.
MATERIALS AND METHODS
Plant Growth
Arabidopsis (Arabidopsis thaliana) seeds (Columbia ecotype) were surface sterilized with 75% ethanol and sown on 0.6% agar petri plates (3.5-cm diameter) containing 1 mm KCl, 1 mm CaCl2, 5 mm MES, pH 5.7, adjusted with Bis-Tris propane. The plates were maintained at 4°C in darkness for 48 to 72 h before transfer to a growth chamber with a 16-h-light/8-h-dark photoperiod and grown vertically for 4 d.
Membrane Potential Measurement
Measurements of membrane potential were made as previously described (Dennison and Spalding, 2000). Data acquisition was performed with a PCI-MIO-16XE-10 analog-to-digital converter (National Instruments) controlled by custom software written in the Labview computer language (National Instruments). The sample rate was 20 Hz. Perfusion of the recording chamber (7 mL min−1) was driven by a peristaltic pump (Dynamax RP-1, Rainin). The initial (control) perfusion solution was the same as the growth medium (minus the agar) and could be switched to one supplemented with an amino acid by electronic valves via the data acquisition software. The inflow tube was positioned as close as possible to the site of impalement to produce an abrupt (within approximately 2 s) exchange of solutions, which aided reproducibility of the resulting ionic responses. Experiments proceeded only if a stable membrane potential more negative than −120 mV was obtained in the control condition.
Measurement of Intracellular Ca2+ with Aequorin
Seeds of Arabidopsis plants expressing aequorin, described previously (Lewis et al., 1997), were sown and grown on agar as described above for 4 d before transfer to a darkroom in which the luminometer equipped with solution injectors (TD-20/20, Turner Designs) was located. For each trial, five seedlings were loaded into a luminometer cuvette containing 200 μL of the growth medium (minus agar) plus 5 μ m coelenterazine (Molecular Probes) and allowed to soak overnight. Programmable, rapid delivery of agonist solutions into the cuvette was performed by the onboard injectors of the luminometer. A computer collected aequorin luminescence readings from the luminometer at 5 Hz. Following each trial, 200 μL of 2 m CaCl2 containing 10% (v/v) ethanol was injected to discharge the remaining aequorin. Integrating this large, luminescence transient produced a value that was used to normalize the experimental response, taking into account any variability in tissue content and coelenterazine uptake among trials. The first 25 s of each normalized recording, which included the entire response to agonist, were integrated, and the integrals for each trial were averaged (Fig. 5A). To express these same data relative to the maximum possible response for each agonist (Fig. 5B), each result was divided by the mean response to a saturating (10 mm) agonist treatment and then multiplied by 100. The small Ca2+ response to buffer-only treatment was also subtracted from each trial value.
Data shown in Figure 1C was obtained in a slightly different manner. Hypocotyls were excised from seedlings with a scalpel and then incubated in 10 μ m coelenterazine overnight. Luminometer cuvettes were loaded with 10 hypocotyls per cuvette and then subjected to agonist treatment while recording luminescence as described above. Each resulting trace was divided by the average pretreatment luminescence to give a fold-increase in signal. Individual trial traces were averaged.
Mutant Genotyping
Seeds of plant lines containing a T-DNA insertion in the gene of interest were obtained from the Salk Institute (http://signal.salk.edu/cgi-bin/tdnaexpress). The lines used here were Salk_040458 (glr3.3-1, second exon insertion), Salk_066009 (glr3.3-2, first intron insertion), Salk_079842 (glr3.4-1, third exon insertion), and Salk_016904 (glr3.4-2, sixth exon insertion). To isolate homozygous mutant individuals, DNA was isolated from leaf samples using a 96-well-plate-based tissue grinder (GenoGrinder 2000; Spex CertiPrep). A left-border T-DNA primer (5′-TGGTTCACGTAGTGGGCCATCG-3′) was used in combination with gene-specific primers to test for the presence or absence of the T-DNA insertion alleles in segregating populations using PCR and agarose gel electrophoresis. The following are gene-specific primers used to confirm the genotype of the glr3.3 and glr3.4 mutant lines: SALK_040458, forward 5′-GAA ACC AAA AGT TGT GAA AAT CGG T-3′, reverse 5′-GAC ACA TTG TCT CTT AGG TGG GCC T-3′; SALK_066009, forward 5′-GAA ACC AAA AGT TGT GAA AAT CGG T-3′, reverse 5′-GAC ACA TTG TCT CTT AGG TGG GCC T-3′; SALK_079842, forward 5′-GTC CAT CCA GAG ACC TTG TAC TCT A-3′, reverse 5′-GCC ATG TTG TGA TTG TGA AGT CCC A-3′; SALK_016904, forward 5′-GTC CAT CCA GAG ACC TTG TAC TCT A-3′, reverse 5′-GCC ATG TTG TGA TTG TGA AGT CCC A-3′.
Supplemental Data
The following materials are available in the online version of this article.
Supplemental Figure S1. Example traces of each of the 36 possible paired ligand treatments.
Supplemental Figure S2. Depolarizations in root cells induced by Gly or Ser were not affected by glr3.4 mutations.
Supplemental Figure S3. Membrane potential achieved 60 s after the application of ligand is a measure of repolarization rate. The more negative the value of V m 60, the more quickly the membrane repolarized. Depolarizations induced by Asn and Ser were the briefest.
Supplemental Table S1. Values of peak membrane potential reached in response to the six effective amino acids in wild type, glr3.3, and glr3.4 mutants.
ACKNOWLEDGMENTS
The authors are grateful for the plant materials supplied by the Arabidopsis Biological Resource Center; to Nathan D. Miller, Departments of Botany and Biomedical Engineering, University of Wisconsin, for constructing the data acquisition software and perfusion control apparatus; and to Cécile Ané, Departments of Statistics and Botany, for advice on statistical methods.
LITERATURE CITED
Acher FC, Bertrand HO (
Arabidopsis Genome Initiative (
Barnes GN, Slevin JT (
Bouché N, Lacombe B, Fromm H (
Brenner ED, Martinez-Barboza N, Clark AP, Liang QS, Stevenson DW, Coruzzi GM (
Chatterton JE, Awobuluyl M, Premkumar LS, Takahashi H, Talantova M, Shin Y, Cul J, Tu S, Sevarino KA, Nakanishi N, et al (
Chiu J, DeSalle R, Lam HM, Meisel L, Coruzzi G (
Chiu JC, Brenner ED, DeSalle R, Nitabach MN, Holmes TC, Coruzzi GM (
Cho MH, Spalding EP (
Dennison KL, Spalding EP (
Dingledine R, Borges K, Bowie D, Traynelis SF (
Dubos C, Huggins D, Grant GH, Knight MR, Campbell MM (
Etherton B, Rubinstein B (
Felder CB, Graul RC, Lee AY, Merkle HP, Sadee W (
Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG (
Ghosh A, Greenberg ME (
Giniatullin R, Nistri A, Yakel JL (
Kang J, Turano FJ (
Kang S, Kim HB, Lee H, Choi JY, Heu S, Oh CJ, Kwon SI, An CS (
Kim SA, Kwak JM, Jae SK, Wang MH, Nam HG (
Kinraide TB, Etherton B (
Kinraide TB, Etherton B (
Lacombe B, Becker D, Hedrich R, DeSalle R, Hollman M, Kwak JM, Schroeder JI, Novère NL, Nam HG, Spalding EP, et al (
Lam HM, Chiu J, Hsieh MH, Meisel L, Oliveira IC, Shin M, Coruzzi G (
Lewis BD, Karlin-Neumann G, Davis RW, Spalding EP (
Li J, Zhu S, Song X, Shen Y, Chen H, Yu J, Yi K, Liu Y, Karplus VJ, Wu P, et al (
Madden DR (
Mayer M (
Meyerhoff O, Müller K, Roelfsema MRG, Latz A, Lacombe B, Hedrich R, Dietrich P, Becker D (
Novacky A, Fischer E, Ullricheberius CI, Lüttge U, Ullrich WR (
Olney JW, Wozniak DF, Farber NB (
Parks BM, Cho MH, Spalding EP (
Qi Z, Stephens NR, Spalding EP (
Schiffer HH (
Sivaguru M, Pike S, Gassmann W, Baskin TI (
Spalding EP, Cosgrove DJ (
Spalding EP, Cosgrove DJ (
Steele AD, Szabo I, Bednar P, Rogers TJ (
Sun Y, Olson R, Horning M, Armstrong N, Mayer M, Gouaux E (
Turano FJ, Panta GR, Allard MW, van Berkum P (
Walch-Liu P, Liu LH, Remans T, Tester M, Forde BG (
Author notes
This work was supported by the U.S. Department of Energy (grant no. 04ER15527 to E.P.S.).
Present address: Baraboo School District, 101 Second Avenue, Baraboo, WI 53913.
Present address: Donald Danforth Plant Science Center, 975 North Warson Road, St. Louis, MO 63132.
Corresponding author; e-mail spalding@wisc.edu.
The author responsible for distribution of materials integral to the findings presented in this article in accordance with the policy described in the Instructions for Authors (www.plantphysiol.org) is: Edgar P. Spalding (spalding@wisc.edu).
The online version of this article contains Web-only data.
Open Access articles can be viewed online without a subscription.






